Nurse Practitioner in Biloxi, MS Accepting Medicare
167 Nurse Practitioner nurses found. Showing 161 - 167
 Deborah Fore, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 971 Tommy Munro Dr, Biloxi, MS 39532 Phone: 662-809-4458 |
 Mr. Bruce Adam Giamalva, FNPC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5000 Fax: 228-523-5731 |
Rachel Lauren Pickich, NP Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5000 |
Daniel Richard Damitio, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 2781 C T Switzer Sr Dr Ste 400, Biloxi, MS 39531 Phone: 228-388-4585 |
Erin Rae Carpenter, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1720a Medical Park Dr Ste 220, Biloxi, MS 39532 Phone: 228-230-2663 Fax: 228-546-3257 |
Kristen Elizabeth Wheelock, NP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 920 Tommy Munro Dr, Biloxi, MS 39532 Phone: 228-396-3167 Fax: 601-496-8101 |
Kelly Susanne Mask, N.P. Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 2798 Pass Rd, Biloxi, MS 39531 Phone: 228-200-0340 Fax: 228-200-0341 |
News Archive
New research: Rhodopsin pigment in Drosophila may detect temperature
New research from Mount Sinai School of Medicine has discovered that rhodopsin, a pigment of the retina that is responsible for the first events in the perception of light, may also be involved in temperature sensation. This detection had not been revealed in previous studies.
New genome-wide association study sheds light on the underlying biology of polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) has been passed down in many families for generations - causing reproductive and metabolic health problems for millions of women around the world. Yet, its cause remains unknown despite more than 80 years of research since the disorder was first described in 1935.
Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial
Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.
Boehringer Ingelheim reports results from SVR12 Phase 3 trial in patients with HCV/HIV co-infection
Today Boehringer Ingelheim announced results from STARTVerso4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg faldaprevir dose groups.
› Verified 3 days ago
Nurse Practitioner
Registered Nurse
Nurse Anesthetist - CR
Physician Assistant